FINHUB Insights

DGX · Q2 FY26 · Apr 1 – Jun 30, 2026

Quest Diagnostics Q2 FY26: where the revenue came from and where it went

Quest Diagnostics Q2 FY26: revenue $3.0B (+10% year over year). Net profit $0.32B. Largest cohort Diagnostic information $3.0B. The whole income statement as a sankey diagram from the SEC filing.

Period
Apr 1 – Jun 30, 2026
Reported
Jul 23, 2026 10-Q
Sankey diagram of Quest Diagnostics's income statement for Q2 FY26: revenue of $3.04 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$3.04B +10% year over year
Gross profit$1.03B 34% margin
Operating profit$0.46B 15% margin
Net profit$0.32B 11% margin

The numbers

All figures in billions of U.S. dollars, for Q2 FY26 (period ends Jun 30, 2026).
ItemValueShare of revenueYear over year
Revenue 3.04 100% +10%
Diagnostic information 2.98 98% +10%
All other 0.07 2% +5%
Cost of revenue−2.0266%
Gross profit1.0334% margin+0pp
SG&A−0.5317%+0pp
Other−0.041%+0pp
Operating profit0.4615% margin−1pp
Tax−0.09
Interest & other costs−0.05
Net profit0.3211%+0pp
Filing on EDGAR More quarters of DGX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.